About Repros Therapeutics Inc.Repros Therapeutics focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. Any statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including the timing of enrollment of patients into Repros’ current clinical trials and studies, the outcome of such clinical trial programs, and such other risks which are identified in the Company's Registration Statement on Form S-1 relating to the above offering. These documents are available on request from Repros Therapeutics or at www.sec.gov . Repros disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For more information, please visit the Company's website at http://www.reprosrx.com.